WCM
ASND icon

Weld Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Weld Capital Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,178
Closed -$470K – 479
2020
Q2 		$470K Buy
+3,178
New +$436K 0.18% 199

Other funds holding ASND

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Weld Capital Management's ASND Position: Q3 2020 in Review

Weld Capital Management sold out of Ascendis Pharma A/S (ASND) in Q3 2020, closing a stake of 3,178 shares — an estimated $470K sold.

Weld Capital Management first reported a position in ASND in Q2 2020 and held it in 1 quarter. The position peaked at $470K in Q2 2020. 152 funds tracked by Wall St. Rank hold ASND as of Q3 2020.

  • Weld Capital Management reported no remaining Ascendis Pharma A/S position as of Q3 2020 after selling out during the quarter.
  • Weld Capital Management sold 3,178 Ascendis Pharma A/S shares in Q3 2020, an estimated $470K.
  • Weld Capital Management first reported a position in Ascendis Pharma A/S in Q2 2020 and held it in 1 quarter.
  • Weld Capital Management's Ascendis Pharma A/S position peaked at $470K in Q2 2020.
  • 152 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2020.

Based on Weld Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.